Login:
 
The Practitioner 2012; 256 (1747):21-26

Targeting CVD risk in chronic connective tissue disease

24 Jan 2012Pais-up subscribers

Chronic inflammatory rheumatological conditions are associated with an increased burden of cardiovascular disease (CVD). In both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) most excess mortality is cardiovascular. The prevalence of subclinical disease indicates that the atherogenic processes start early in the course of inflammatory disease. Although less data are available regarding the extent of the problem in other inflammatory arthritides or connective tissue diseases, increased CVD risk is also associated with psoriatic arthritis, ankylosing spondylitis, antiphospholipid syndrome and systemic sclerosis. Management of CVD risk in these patient groups is hampered by the complexity of both the underlying disorder and its treatment, and by the lack of clear guidelines for either primary or secondary care teams.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article